CEBP-gamma (DNA binding domain, residues 39-147, Human)

Category: Proteins
Catalog
01-2224G
(Ships in 5-10 business days)

Questions? Contact us

Call (800) 832-2611

arp-guarantee
- +
$0.00
More Information
Product Name CEBP-gamma (DNA binding domain, residues 39-147, Human)
Description CCAAT/enhancer binding protein(C/EBP) gamma is a family of transcription factors all contain a highly conserved, basic-leucine zipper domain at the C-terminus that is involved in dimerization and DNA binding. C/EBP family of transcription factors regulates viral and cellular CCAAT/enhancer element-mediated transcription. C/EBP family consist of several related proteins, C/EBP alpha, beta gamma, delta, that form homodimers and/or form heterodimers with each other. C/EBP proteins contain the bZIP region, which is characterized by two motifs in the C-terminal half of the protein; a basic region involved in DNA binding and a leucine zipper motif involved in dimerization. C/EBP gamma may cooperate with Fos to bind PRE- enhancer elements. The DNA binding domain of CEBP-gamma (amino acid residues, 39-147) was produced in E.coli and purified by using conventional chromatography techniques.
Synonyms CEBPG, CEBP-gamma, His-tag (DNA binding domain, residues), C/EBP gamma, CCAAT/enhancer-binding protein gamma, CCAAT/enhancer binding protein g C/EBP gamma, CCAAT/enhancer binding protein (C/EBP) gamma, CCAAT/enhancer binding protein gamma, GPE1BP, IG/EBP 1, IG/EBP1,
Host E.coli
Molecular Weight 14 kDa (129 aa), confirmed by MALDI-TOF.
Amino Acid Sequence MRGSHHHHHH GMASMTGGQQ MGRDLYDDDD KDRWGSMPGG GGKAVAPSKQ SKKSSPMDRN SDEYRQRRER NNMAVKKSRL KSKQKAQDTL QRVNQLKEEN ERLEAKIKLL TKELSVLKDL FLEHAHNLAD NVQSISTENT TADGDN
Tag His-tag
Reactivity Human
Applications SDS-PAGE
Form Liquid, in Phosphate-Buffered Saline (pH 7.4) , 40%glycerol, 2mM DTT, 0.1mM PMSF, 1mM EDTA
Concentration 0.5 mg/ml (determined by Bradford assay)
Purity > 95% by SDS-PAGE
Storage Can be stored at +4C short term (1-2 weeks). For long term storage, aliquot and store at -20C or -70C. Avoid repeated freezing and thawing cycles.
References Hattori,T., et al (2003) Oncogene 22(9). ,1273-1280
Davydov,I., et al(1995) Gene. 161(2) ; 271-275
Williams, S.C.,et al (1991) Genes Dev. 5(9) ; 1553-1567
Supplier ARP

All Research Products are sold for laboratory RESEARCH USE ONLY and ARE NOT TO BE USED FOR HUMAN OR ANIMAL THERAPEUTIC OR DIAGNOSTIC APPLICATIONS. The information presented is believed to be accurate; however, said information and products are offered without warranty or guarantee since the ultimate conditions of use and the variability of the materials treated are beyond our control. Nothing disclosed herein is to be construed as a recommendation to use our products in violation of any patents. ARP American Research Products, Inc. does not submit its products for regulatory review by any government body or other organization, and we do not validate them for clinical, therapeutic or diagnostic use, or for safety and effectiveness. You are solely responsible for making sure that the way you use the products complies with applicable laws, regulations and governmental policies and for obtaining all necessary approvals, intellectual property rights, licenses and permissions that you may need related to your use. Under no circumstances shall ARP American Research Products, Inc. be liable for damages, whether consequential, compensatory, incidental or special, strict liability or negligence, breach of warranty or any other theory arising out of the use of the products available from ARP American Research Products, Inc. Nothing contained herein warrants that the use of the products will not infringe on the claims of any patents covering the product itself or the use thereof in combination with other products or in the operation of any process. ARP American Research Products, Inc. disclaims any and all representations or warranties of any kind whatsoever, express or implied, including without limitation any implied warranties of merchantability or fitness for a particular purpose, of non-infringement, or regarding results obtained through the use of any product, whether arising from a statute or otherwise in law or from a course of performance, dealing or usage of trade.